Here is the latest stock price and chart of DIVIS LABORATORIES. For more details, see the DIVIS LABORATORIES company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since large caps interest you, here's our guide to buying bluechip stocks.
Announcement: Discover Richa's Top 3 Stock Picks for 2022...
Live BSE Quotes | May 19, 2022 (Close) | ||
---|---|---|---|
Price (Rs)4,200.50 | Open (Rs) 4,245.00 | High (Rs) 4,330.45 | Low (Rs) 4,191.60 |
% Change-3.78 | Volume 5,720 | Value (Rs) 24,335,967 | 52-Week H/L 5,425.00 / 3,790.00 |
Live NSE Quotes | May 19, 2022 (Close) | ||
---|---|---|---|
Price (Rs)4,199.20 | Open (Rs) 4,281.00 | High (Rs) 4,336.95 | Low (Rs) 4,190.00 |
% Change-3.84 | Volume 288,480 | Value (Rs) 1,224,880,599 | 52-Week H/L 5,425.10 / 3,788.95 |
Change | |||||
---|---|---|---|---|---|
1 Day -3.78% | 1 Month -4.63% | 3 Months -1.46% | 1 Year 3.99% | 5 Years (CAGR)* 47.03% | 10 Years (CAGR)* 16.31% |
* Compound Annual Growth Rate
Valuation | ||||
---|---|---|---|---|
EPS (Rs)* 96.73 | P/E Ratio (x) 43.43 | Market Cap (Rs m) 1,115,100.85 | P/BV (x) 12.00 | Dividend Yield (%) 0.48 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
DIVIS LABORATORIES last traded price was down 3.8% to Rs 4,200.5 on the BSE. On the NSE, DIVIS LABORATORIES last traded price was down 3.8% to Rs 4,199.2. The total volume of shares traded was 0.3 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 2.2%. And the benchmark S&P BSE SENSEX was at 52,792.2 (down 2.6%).
Over the last 30 days, the DIVIS LABORATORIES share price is down 7.1%. And over the last one year, DIVIS LABORATORIES share price is up 5.1%.
The current market capitalisation of DIVIS LABORATORIES stands at Rs 1,115,100.85 m. For more information, check out the list of top 100 companies in India in terms of market cap.
As of March 2022, company promoters held 51.94% stake in DIVIS LABORATORIES, with no shares having been pledged. To know more, check out the latest shareholding pattern of DIVIS LABORATORIES.
What else is happening in the markets today? Dig in...
Indian share markets remained in the bear grip throughout the trading session today tracking extremely weak global cues.
The stock jumped 3.6% in intraday trade to hit its 52-week high.
During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.
The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?
For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.
The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.
More Views on NewsWe are just two months into 2022 and several penny stocks that we track have already surged 5x.
Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.
A step-by-step method to pick the best penny stocks for the long term.
These penny stocks can become future multibaggers. Watch out for them.
Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?
More